Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Continuous dopaminergic stimulation, pulsatile dopaminergic stimulation]

A. Destée1, R. Bordet

  • 1Clinique Neurologique, EA 2683 MENRT, Service de Pharmacologie clinique, EA 1046 MNERT, CHU Lillle.

Revue Neurologique
|April 12, 2003
PubMed
Summary

Levodopa is the standard Parkinson's disease treatment, but motor complications like dyskinesia can occur. Achieving stable dopaminergic stimulation is key, with alternatives like agonists or modulating levodopa

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Beyond migraine: A narrative review of photophobia's clinical spectrum.

Revue neurologique·2026
Same journal

Macrophage inclusions in patients undergoing antisense oligonucleotide therapy for ALS or SMA: A retrospective and transversal study.

Revue neurologique·2026
Same journal

Geographic disparities in MRI features of ischemic stroke and small vessel disease: A comparative study between French Guiana and mainland France. Findings from the BECATOUR multicenter registry.

Revue neurologique·2026
Same journal

Continuous subcutaneous perfusion of apomorphine in Parkinson's disease: Towards monotherapy?

Revue neurologique·2026
Same journal

Neuro-Whipple presenting as autoimmune encephalitis.

Revue neurologique·2026
Same journal

Multimodal assessment of minimally conscious state and cognitive motor dissociation in neurocritical care: A critical review.

Revue neurologique·2026

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Levodopa is the primary treatment for Parkinson's disease (PD).
  • Motor complications, including fluctuating motor control and dyskinesia, frequently arise with levodopa therapy, especially in younger patients.
  • Pulsed dopaminergic stimulation is implicated in the pathophysiology of these motor complications.

Purpose of the Study:

  • To explore strategies for optimizing dopaminergic stimulation in Parkinson's disease management.
  • To address the limitations of levodopa therapy by minimizing motor complications.

Main Methods:

  • Review of pathophysiological mechanisms underlying levodopa-induced motor complications.
  • Evaluation of alternative therapeutic approaches to levodopa.

Main Results:

Related Experiment Videos

  • Pulsed dopaminergic stimulation plays a critical role in motor complications.
  • Stable and physiological dopaminergic stimulation is crucial for effective PD treatment.
  • Dopaminergic agonists and catechol-O-methyl transferase (COMT) inhibitors show promise.

Conclusions:

  • Optimizing dopaminergic stimulation is essential for managing Parkinson's disease.
  • Dopaminergic agonists offer a potential alternative to levodopa.
  • Modulating levodopa's peripheral kinetics with COMT inhibitors is a viable strategy to improve treatment outcomes.